143 related articles for article (PubMed ID: 12583839)
1. Gene expression profiling to analyze embryonal tumors of the central nervous system.
Packer RJ
Curr Neurol Neurosci Rep; 2003 Mar; 3(2):117-9. PubMed ID: 12583839
[No Abstract] [Full Text] [Related]
2. Targeting Myc in pediatric malignancies of the central and peripheral nervous system.
Grotzer MA; Castelletti D; Fiaschetti G; Shalaby T; Arcaro A
Curr Cancer Drug Targets; 2009 Mar; 9(2):176-88. PubMed ID: 19275758
[TBL] [Abstract][Full Text] [Related]
3. Microrna expression signatures predict patient progression and disease outcome in pediatric embryonal central nervous system neoplasms.
Braoudaki M; Lambrou GI; Giannikou K; Milionis V; Stefanaki K; Birks DK; Prodromou N; Kolialexi A; Kattamis A; Spiliopoulou CA; Tzortzatou-Stathopoulou F; Kanavakis E
J Hematol Oncol; 2014 Dec; 7():96. PubMed ID: 25551588
[TBL] [Abstract][Full Text] [Related]
4. hTERT gene amplification and increased mRNA expression in central nervous system embryonal tumors.
Fan X; Wang Y; Kratz J; Brat DJ; Robitaille Y; Moghrabi A; Perlman EJ; Dang CV; Burger PC; Eberhart CG
Am J Pathol; 2003 Jun; 162(6):1763-9. PubMed ID: 12759234
[TBL] [Abstract][Full Text] [Related]
5. Chemotherapy for medulloblastoma/primitive neuroectodermal tumors of the posterior fossa.
Packer RJ
Ann Neurol; 1990 Dec; 28(6):823-8. PubMed ID: 2178331
[TBL] [Abstract][Full Text] [Related]
6. Activity of postoperative carboplatin, etoposide, and high-dose methotrexate in pediatric CNS embryonal tumors: results of a phase II study in newly diagnosed children.
Kellie SJ; Wong CK; Pozza LD; Waters KD; Lockwood L; Mauger DC; White L
Med Pediatr Oncol; 2002 Sep; 39(3):168-74. PubMed ID: 12210445
[TBL] [Abstract][Full Text] [Related]
7. Medulloblastoma: need for targeted treatment.
Luttjeboer M; Kaspers GJ
Expert Rev Anticancer Ther; 2006 May; 6(5):649-52. PubMed ID: 16759156
[No Abstract] [Full Text] [Related]
8. [Medulloblastoma. Pathology].
Siegfried A; Delisle MB
Neurochirurgie; 2021 Feb; 67(1):28-38. PubMed ID: 29703584
[TBL] [Abstract][Full Text] [Related]
9. Matching mice to malignancy: molecular subgroups and models of medulloblastoma.
Lau J; Schmidt C; Markant SL; Taylor MD; Wechsler-Reya RJ; Weiss WA
Childs Nerv Syst; 2012 Apr; 28(4):521-32. PubMed ID: 22315164
[TBL] [Abstract][Full Text] [Related]
10. Genomics identifies medulloblastoma subgroups that are enriched for specific genetic alterations.
Thompson MC; Fuller C; Hogg TL; Dalton J; Finkelstein D; Lau CC; Chintagumpala M; Adesina A; Ashley DM; Kellie SJ; Taylor MD; Curran T; Gajjar A; Gilbertson RJ
J Clin Oncol; 2006 Apr; 24(12):1924-31. PubMed ID: 16567768
[TBL] [Abstract][Full Text] [Related]
11. In vitro karyotypic and immunophenotypic characterisation of primitive neuroectodermal tumours: similarities to malignant gliomas.
Jennings MT; Jennings DL; Ebrahim SA; Johnson MD; Turc-Carel C; Philip T; Philip I; Lapras C; Shapiro JR
Eur J Cancer; 1992; 28A(4-5):762-6. PubMed ID: 1326305
[TBL] [Abstract][Full Text] [Related]
12. Combined p53 and MYC Alterations Are Common in Relapsed Medulloblastoma.
Cancer Discov; 2015 Feb; 5(2):OF7. PubMed ID: 25656905
[No Abstract] [Full Text] [Related]
13. Cerebellar primitive neuroectodermal tumor with multipotent differentiation in a family with von Hippel-Lindau disease. Case report.
Becker R; Bauer BL; Mennel HD; Plate KH
Clin Neuropathol; 1993; 12(2):107-11. PubMed ID: 8386599
[TBL] [Abstract][Full Text] [Related]
14. MicroRNAs in pediatric central nervous system embryonal neoplasms: the known unknown.
Braoudaki M; Lambrou GI
J Hematol Oncol; 2015 Feb; 8():6. PubMed ID: 25652781
[TBL] [Abstract][Full Text] [Related]
15. Exploiting Laboratory Insights to Improve Outcomes of Pediatric Central Nervous System Tumors.
Robinson GW; Witt H; Resnick A
Am Soc Clin Oncol Educ Book; 2016; 35():e540-6. PubMed ID: 27249765
[TBL] [Abstract][Full Text] [Related]
16. Anaplasia and grading in medulloblastomas.
Eberhart CG; Burger PC
Brain Pathol; 2003 Jul; 13(3):376-85. PubMed ID: 12946027
[TBL] [Abstract][Full Text] [Related]
17. Class III beta-tubulin isotype: a key cytoskeletal protein at the crossroads of developmental neurobiology and tumor neuropathology.
Katsetos CD; Legido A; Perentes E; Mörk SJ
J Child Neurol; 2003 Dec; 18(12):851-66; discussion 867. PubMed ID: 14736079
[TBL] [Abstract][Full Text] [Related]
18. Advances in the biology and treatment of pediatric central nervous system tumors.
Vitanza NA; Cho YJ
Curr Opin Pediatr; 2016 Feb; 28(1):34-9. PubMed ID: 26709691
[TBL] [Abstract][Full Text] [Related]
19. Molecular biology of medulloblastoma: will it ever make a difference to clinical management?
Gilbertson RJ; Gajjar A
J Neurooncol; 2005 Dec; 75(3):273-8. PubMed ID: 16195803
[TBL] [Abstract][Full Text] [Related]
20. In vitro and in vivo variation in transferrin receptor expression on a human medulloblastoma cell line.
Wen DY; Hall WA; Conrad J; Godal A; Flørenes VA; Fodstad O
Neurosurgery; 1995 Jun; 36(6):1158-63; discussion 1163-4. PubMed ID: 7643997
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
